Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | CNR2 | P34972 | 7/20 | 0.48 |
| ▸ | CNR1 | P21554 | 6/20 | 0.48 |
| ▸ | DGKA | P23743 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.46 |
| ▸ | ELANE | P08246 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11546979 | 1.00 | KMT2A (0.50) | KMT2ASMN1; SMN2CNR2CNR1DGKA | |
| SCHEMBL14831865 | 1.00 | KMT2A (0.50) | KMT2ASMN1; SMN2CNR2CNR1DGKA | |
| SCHEMBL675476 | 1.00 | KMT2A (0.50) | KMT2ASMN1; SMN2CNR2CNR1DGKA | |
| SCHEMBL14060911 | 1.00 | KMT2A (0.50) | KMT2ASMN1; SMN2CNR2CNR1DGKA | |
| SCHEMBL15463445 | 0.98 | KMT2A (0.48) | KMT2ASMN1; SMN2CNR2CNR1DGKA | |
| SCHEMBL9752590 | 0.93 | KMT2A (0.45) | KMT2ASMN1; SMN2CNR2CNR1PTGS2 | |
| SCHEMBL8653636 | 0.91 | KMT2A (0.47) | KMT2ASMN1; SMN2CNR2CNR1 | |
| SCHEMBL8653228 | 0.91 | KMT2A (0.47) | KMT2ASMN1; SMN2CNR2CNR1 | |
| SCHEMBL8652802 | 0.91 | KMT2A (0.47) | KMT2ASMN1; SMN2CNR2CNR1 | |
| SCHEMBL8651624 | 0.91 | KMT2A (0.47) | KMT2ASMN1; SMN2CNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020196073-A1 | REVERSIBLE THERMOCHROMIC MICROCAPSULE PIGMENT | パイロットインキ株式会社 | 2020-10-01 | — | — | WO | disclosed |